Yoshitaka Totani Yuji Saito Masamichi Hayashi Toshihiko Tada Yasuo Kohashi Yuki Mieno Atsushi Kato Hiromi Imizu Yukiko Yoneda Tami Hoshino Yasuhiro Uchiyama Yasuo Takeuchi Mitsushi Okazawa Hiroki Sakakibara
CANCER CHEMOTHERAPY AND PHARMACOLOGY 64(6) 1181-1185 2009年11月 [査読有り]
To assess the efficacy and toxicity of an oral anticancer fluoropyrimidine derivative, S-1, for previously treated patients with advanced non-small cell lung cancer (NSCLC).
Patients with advanced (clinical stage IIIB-IV) NSCLC who had previously ...
お知らせ・マニュアル
医学部